Jeffrey T. L. Smith, Senior VP Translational Medicine at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 3,000 shares at $22.61 ($68K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Open-market sale of $68k ALDR by Senior VP Translational Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.61 | 2,500 | $57K | 82.7% |
| 2 | $23.62 | 500 | $12K | 17.3% |
| Total | $22.78 avg | 3,000 | $68K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |